The role of inorganic chemistry in the development of radiometal agents for cancer therapy

被引：92

作者：

Heeg, MJ

Jurisson, SS ^{[1
]}

机构：

[1] Univ Missouri, Res Reactor, Columbia, MO 65211 USA

[2] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA

[3] Univ Missouri, Dept Chem, Columbia, MO 65211 USA

来源：

ACCOUNTS OF CHEMICAL RESEARCH | 1999年 / 32卷 / 12期

关键词：

D O I：

10.1021/ar980002c

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

[No abstract available]

引用

页码：1053 / 1060

页数：8

共 83 条

[1]

Alberto R, 1997, RADIOCHIM ACTA, V79, P99

[2]

ANDERSON CJ, 1995, J NUCL MED, V36, P2315

[3] Radioiodine and thyroid disease: The beginning [J].

Becker, DV ;

Sawin, CT .

SEMINARS IN NUCLEAR MEDICINE, 1996, 26 (03) :155-164

[4] SR-89 THERAPY - STRONTIUM KINETICS IN DISSEMINATED CARCINOMA OF THE PROSTATE [J].

BLAKE, GM ;

ZIVANOVIC, MA ;

MCEWAN, AJ ;

ACKERY, DM .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1986, 12 (09) :447-454

[5]

BONIFACE GR, 1989, J NUCL MED, V30, P683

[6]

BRADY LW, 1995, CANCER, V76, P2143, DOI 10.1002/1097-0142(19951115)76:10+<2143::AID-CNCR2820761339>3.0.CO

[7]

2-4

[8]

BREITZ HB, 1992, J NUCL MED, V33, P1099

[9]

BROCKMANN J, 1997, P 12 INT S RAD CHEM, P468

[10]

Cleaves Margaret, 1903, MED REC, V64, P601

← 1 2 3 4 5 6 7 8 9 →